4-(Methylamino)azobenzene

CAS: 621-90-9

Ref. 3D-AAA62190

Produktinformation

• Name: 4-(Methylamino)azobenzene
• Synonyme: Aniline, N-methyl-p-(phenylazo)-, Benzenamine, N-methyl-4-(2-phenyldiazenyl)-, Benzenamine, N-methyl-4-(phenylazo)-, N-Methyl-4-(2-phenyldiazenyl)benzenamine, N-Methyl-4-(phenylazo)aniline, N-Methyl-4-aminoazobenzene, N-methyl-4-[(E)-phenyldiazenyl]aniline, p-(Methylamino)azobenzene, p-(Phenylazo)-N-methylaniline, p-N-Methylaminoazobenzene, MAB

Beschreibung

4-(Methylamino)azobenzene is an experimental drug that has shown to be effective in the treatment of different types of cancers. It is a potential candidate for the treatment of infectious diseases, such as tuberculosis and leprosy, because it targets the surface glycoprotein (GP1bα), which may be involved in the development of these diseases. 4-(Methylamino)azobenzene may also have anticancer properties, although this has not been confirmed. This molecule can trigger cell lysis by binding to intracellular targets such as toll-like receptor 4, which is involved in inflammation and immunity.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 211.27 g/mol
• Formel: C₁₃H₁₃N₃
• Reinheit: Min. 95%